SCHEMBL3469744

SCHEMBL3469744

N=C(NO)c1ccc2c(ccn2CC(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.51
▸ PPARD Q03181 4/20 0.50
▸ PPARG P37231 3/20 0.50
▸ PPARA Q07869 3/20 0.50
▸ PLG P00747 3/20 0.46
▸ PLAU P00749 3/20 0.46
▸ HDAC8 Q9BY41 5/20 0.45
▸ HDAC6 Q9UBN7 5/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC3 O15379 4/20 0.44
▸ HDAC1 Q13547 4/20 0.44
▸ HDAC2 Q92769 4/20 0.44
▸ ITGB3 P05106 1/20 0.43
▸ ITGA2B P08514 1/20 0.43
▸ F2 P00734 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.42
▸ NTSR1 P30989 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28607801 0.82 KMT2A (0.60) KMT2APPARDPPARGPPARAPLG
SCHEMBL418013 0.76 KMT2A (0.60) KMT2APPARDPPARGPPARANTSR1
SCHEMBL400167 0.75 TNF (0.47) PLGPLAUHDAC8HDAC6HDAC11
Trifluoroacetic Acid SCHEMBL2950617 0.75 PLG (0.44) PPARGPLGPLAUHDAC8HDAC6
SCHEMBL30103437 0.74 KMT2A (0.62) KMT2APPARDPPARGPPARAITGB3
SCHEMBL4234811 0.74 KMT2A (0.62) KMT2APPARDPPARGPPARAITGB3
SCHEMBL4616598 0.74 PLAU (0.51) PLGPLAUHDAC8HDAC6HDAC11
SCHEMBL2414207 0.73 MAOB (0.49) KMT2APLGPLAUHDAC6
SCHEMBL19145535 0.73 KMT2A (0.60) KMT2APPARDPPARGPPARAITGB3
SCHEMBL5537950 0.73 KMT2A (0.60) KMT2APPARDPPARGPPARAHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376484-B1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO SA (CH) 2015-04-22 — — EP disclosed
US-8741923-B2 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis MERCK SERONO SA (CH) 2014-06-03 — — US disclosed
WO-2010069949-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO S.A. (CH) 2010-06-24 — — WO disclosed
Send feedback